What IBS drug is being discontinued? A Look at Zelnorm and Other Changes
•
3 min read
Effective June 30, 2022, the manufacturer Alfasigma withdrew the irritable bowel syndrome with constipation (IBS-C) medication Zelnorm (tegaserod) from the U.S. market for business reasons. This followed an earlier recall driven by safety concerns.
